Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


18.03.2019

1 Am J Hematol
1 Am J Surg Pathol
1 Blood
1 BMC Cancer
2 Br J Haematol
2 Int J Radiat Oncol Biol Phys
1 Leukemia
1 Oncogene


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. LIU Y, Barta SK
    Diffuse Large B cell Lymphoma: 2019 update on diagnosis, risk-stratification and treatment.
    Am J Hematol. 2019 Mar 11. doi: 10.1002/ajh.25460.
    PubMed     Text format     Abstract available


    Am J Surg Pathol

  2. MOORE EM, Swerdlow SH, Gibson SE
    Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
    Am J Surg Pathol. 2018;42:342-350.
    PubMed     Text format     Abstract available


    Blood

  3. ZELENETZ AD, Salles G, Mason KD, Casulo C, et al
    Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.
    Blood. 2019 Mar 8. pii: blood-2018-11-880526. doi: 10.1182/blood-2018-11-880526.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. HAO B, Zhao L, Luo NN, Ruan D, et al
    Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using (18)F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy.
    BMC Cancer. 2018;18:1192.
    PubMed     Text format     Abstract available


    Br J Haematol

  5. PAVLOVSKY A, Fernandez I, Kurgansky N, Prates V, et al
    PET-adapted therapy after three cycles of ABVD for all stages of Hodgkin lymphoma: results of the GATLA LH-05 trial.
    Br J Haematol. 2019 Mar 12. doi: 10.1111/bjh.15838.
    PubMed     Text format     Abstract available

  6. HAPGOOD G, Ben-Neriah S, Mottok A, Lee DG, et al
    Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
    Br J Haematol. 2019 Mar 14. doi: 10.1111/bjh.15860.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  7. KELSEY CR, Broadwater G, James O, Chino J, et al
    Phase II Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2019 Mar 8. pii: S0360-3016(19)30313.
    PubMed     Text format     Abstract available

  8. BINKLEY MS, Brady JL, Hajj C, Chelius M, et al
    Salvage treatment and survival for relapsed follicular lymphoma following primary radiotherapy: A collaborative study on behalf of ILROG.
    Int J Radiat Oncol Biol Phys. 2019 Mar 8. pii: S0360-3016(19)30317.
    PubMed     Text format     Abstract available


    Leukemia

  9. SASI BK, Martines C, Xerxa E, Porro F, et al
    Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma.
    Leukemia. 2019 Mar 14. pii: 10.1038/s41375-019-0442.
    PubMed     Text format     Abstract available


    Oncogene

  10. DING L, Zhang Y, Han L, Fu L, et al
    Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis.
    Oncogene. 2018;37:1293-1307.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: